This pro-apoptotic BCL2 family member is upregulated by inhibition of ERK signaling (Collins et al., 2005) and in BRAFV600E melanoma cells treated with vemurafenib (Paraiso et al., 2011). This evidence concerns the gene BCL2 and melanoma.